Farms.com Home   News

CCGA Earns Kincentric Best Employer Canada 2024 Recognition

Canadian Canola Growers Association (CCGA) thanks its employees for their care and dedication in making CCGA a great place to work! Earlier this week, CCGA was recognized as a Kincentric Best Employer Canada 2024, an award that highlights workplaces where people feel empowered, inspired, and engaged.

"Building a culture that encourages all of us to actively make CCGA a better place for our people and the farmers that we serve takes commitment from the entire team," says Rick White, President & CEO. "We believe in creating a workplace that balances the needs of our people and the needs of the organization so that we can make a meaningful difference in agriculture."

Kincentric Best Employers recognition is much more than just scoring well on specific metrics—it's about people, organization culture, employee experience, and the outcome is completely driven by employee feedback. To achieve best employer status, employees assess their employer on four critical factors including employee engagement, organization agility, engaging leadership, and talent focus."

"We're continually adapting our work environment so employees feel supported and can remain agile and involved," says Larysa Motruk, Vice-President of Human Resources. "The policies and systems we've created around our people strive to attract and retain talented employees who believe in supporting each other and our vision of helping farmers succeed. Our employees are the foundation of what we do, and it's rewarding to be honoured with this award."

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.